Journal article
Consensus clinical management guidelines for Niemann-Pick disease type C
T Geberhiwot, A Moro, A Dardis, U Ramaswami, S Sirrs, MP Marfa, MT Vanier, M Walterfang, S Bolton, C Dawson, B Héron, M Stampfer, J Imrie, C Hendriksz, P Gissen, E Crushell, MJ Coll, Y Nadjar, H Klünemann, E Mengel Show all
Orphanet Journal of Rare Diseases | BMC | Published : 2018
Open access
Abstract
Niemann-Pick Type C (NPC) is a progressive and life limiting autosomal recessive disorder caused by mutations in either the NPC1 or NPC2 gene. Mutations in these genes are associated with abnormal endosomal-lysosomal trafficking, resulting in the accumulation of multiple tissue specific lipids in the lysosomes. The clinical spectrum of NPC disease ranges from a neonatal rapidly progressive fatal disorder to an adult-onset chronic neurodegenerative disease. The age of onset of the first (beyond 3 months of life) neurological symptom may predict the severity of the disease and determines life expectancy. NPC has an estimated incidence of ~ 1: 100,000 and the rarity of the disease translate int..
View full abstractGrants
Funding Acknowledgements
This publication arises from the project 'International Niemann-Pick Disease Registry' which has received funding from the European Union, in the framework of the Health Programme.